Joseph John to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Joseph John has written about Randomized Controlled Trials as Topic.
Connection Strength
0.051
-
Drug evaluation: tefibazumab--a monoclonal antibody against staphylococcal infection. Curr Opin Mol Ther. 2006 Oct; 8(5):455-60.
Score: 0.051
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.